Background
Methods
Data source
Study definitions
Statistical analysis
Results
Characteristic | Pregnant womena
| Pregnant womenawith an ICD-9-CM diagnostic code for CMV disease | ||
---|---|---|---|---|
# | % | # | % | |
Age Group (years)
| ||||
15-19 | 2,955 | 3.8% | 0 | 0.0% |
20-29 | 30,819 | 39.6% | 4 | 33.3% |
30-39 | 40,815 | 52.5% | 8 | 66.7% |
40-44 | 3,184 | 4.1% | 0 | 0.0% |
Urban Residence
| ||||
No | 10,592 | 13.6% | 2 | 16.7% |
Yes | 67,181 | 86.4% | 10 | 83.3% |
Region
b
| ||||
Northeast | 9,674 | 12.5% | 1 | 8.3% |
North Central | 21,206 | 27.3% | 3 | 25.0% |
South | 34,781 | 44.8% | 5 | 41.7% |
West | 11,970 | 15.4% | 3 | 25.0% |
Diagnostic Code for Infectious Mononucleosis
c
| ||||
No | 77,729 | 99.9% | 12 | 100.0% |
Yes | 44 | 0.1% | 0 | 0.0% |
Pregnant womenawith CMV-specific testingb
| Pregnant womenawith an ICD-9-CM diagnostic code for CMV disease and CMV-specific testingb
| |||
---|---|---|---|---|
N, 1,668 | N, 10 | |||
# | % | # | % | |
Type of CMV-specific Test
b
| ||||
CMV PCR ONLY | 17 | 1% | 1 | 10% |
CMV DFA ONLY | 1 | 0% | 0 | 0% |
CMV Serology ONLY (CMV IgG, IgM, and EIA) | 741 | 44% | 5 | 50% |
CMV PCR AND CMV Serology | 8 | 0% | 0 | 0% |
CMV PCR AND Non-Specific Culture or PCR | 24 | 1% | 2 | 20% |
CMV PCR, CMV Serology, AND Non-specific Culture or PCR | 13 | 1% | 0 | 0% |
CMV DFA, CMV Serology, AND Non-Specific Culture or PCR | 1 | 0% | 0 | 0% |
CMV Serology AND Non-specific Culture or PCR | 863 | 52% | 2 | 20% |
Gestational Age when CMV-Specific Testing Conducted
c
| ||||
1st Trimester | 863 | 52% | 5 | 50% |
2nd Trimester | 395 | 24% | 4 | 40% |
3rd Trimester | 410 | 24% | 1 | 10% |
Factor | Pregnant womenb
| |||
---|---|---|---|---|
Total | # Tested | % Tested | p-Value | |
Age Group (years)
| ||||
15-19 | 2,955 | 22 | 0.7% | <0.001 |
20-29 | 30,819 | 519 | 1.7% | |
30-39 | 40,815 | 1,022 | 2.5% | |
40-44 | 3,184 | 105 | 3.3% | |
Urban Residence
| ||||
No | 10,592 | 65 | 0.6% | <0.001 |
Yes | 67,181 | 1,603 | 2.4% | |
Region
c
| ||||
Northeast | 9,674 | 628 | 6.5% | <0.001 |
North Central | 21,206 | 313 | 1.5% | |
South | 34,781 | 579 | 1.7% | |
West | 11,970 | 148 | 1.2% | |
Diagnostic Code for Infectious Mononucleosis
d
| ||||
No | 77,729 | 1,662 | 2.1% | <0.001 |
Yes | 44 | 6 | 13.6% |
Routinely recommended laboratory tests for pregnant womena
| Pregnant womena
| Pregnant womenawith CMV-specific testingb
|
---|---|---|
# (%) | # (%) | |
Anemia testing | 10,033 (13) | 146 (1.5) |
Glucose testing | 54,989 (71) | 1,228 (2.2) |
Urine testing | 54,947 (71) | 1,311 (2.4) |
Syphilis testing | 65,047 (84) | 1,613 (2.5) |
Chlamydia testing | 49,730 (64) | 1,225 (2.5) |
HIV testing | 57,262 (74) | 1,530 (2.7) |
Hepatitis B testing | 23,011 (30) | 800 (3.5) |
Rubella testing | 15,546 (20) | 650 (4.2) |
Discussion
Conclusions
Appendix
ICD-9-CM/CPT code(s) | Code description |
---|---|
CMV Laboratory Testing
| |
CPT 86644-5 | CMV Antibody Testing |
CPT 87271 | CMV Direct fluorescent antibody (DFA) Testing |
CPT 87332 | CMV enzyme immunoassay |
CPT 87495-87497 | CMV Infectious agent detection by nucleic acid (DNA or RNA) |
CPT 87252, 87254 | Non-specific virus isolation by culture |
CPT 83890–1, 83898, 83900–2, 83904–9, 83912, 87800-1 | Non-specific molecular diagnostics or infectious agent detection (DNA or RNA) |
Pregnancy Delivery
| |
ICD-9-CM 650 | Normal Delivery |
ICD-9-CM 658.1-3 | Premature rupture of membranes or delayed delivery after spontaneous, unspecified, or artificial rupture of membranes |
ICD-9-CM 659 | Other indications for care or intervention related to labor and delivery, not elsewhere classified |
ICD-9-CM 66x.x | Complications of labor and delivery |
ICD-9-CM 67x.x | Complications of Puerperium (period right after delivery) |
ICD-9-CM V24.0 | Postpartum care and examination, immediately after delivery |
ICD-9-CM V27.x | Outcome of delivery |
ICD-9-CM 69.02, 69.52 | Dilation and curettage or aspiration curettage of uterus, following delivery or abortion |
ICD-9-CM 72.x-74.x | Delivery procedures |
CPT 01958, 01960–2, 01967-9 | Anesthesia for delivery |
CPT 59200 | Insertion cervical dilator |
CPT 59300 | Episiotomy or vaginal repair |
CPT 59400-59414 | Vaginal Delivery |
CPT 59510, 59514 | Cesarean Delivery |
CPT 59610, 59612, 59618, 59620 | Delivery after previous cesarean delivery |
Prenatal Care
| |
ICD-9-CM 64x.x | Complications of pregnancy |
ICD-9-CM V22.xx | Normal pregnancy |
ICD-9-CM V23.xx | Supervision high-risk pregnancy |
ICD-9-CM V72.42 | Pregnancy examination or test, positive result |
ICD-9-CM 75.1 | Diagnostic amniocentesis |
ICD-9-CM 75.2 | Intrauterine transfusion |
ICD-9-CM 75.3 | Other intrauterine operations on fetus and amnion |
CPT 59000 | Amniocentesis, diagnostic |
CPT 59001-59076 | Antepartum services |
CPT 59618 | Routine obstetric care including antepartum care, cesarean delivery, and postpartum care, following attempted vaginal delivery after previous cesarean delivery |
CPT 59897 | Unlisted fetal invasive procedure, including ultrasound guidance |
CPT 76801-76828 | Obstetrical ultrasound |
CPT 76941 | Ultrasound guidance for fetal transfusion or cordocentesis |
CPT 76945 | Ultrasound guidance for chorionic villus sampling |
CPT 76946 | Ultrasound guidance for amniocentesis |
CPT 80055 | Obstetric panel |
CPT 82105-7 | Serum alpha-fetoprotein |
CPT 82143 | Amniotic fluid scan (spectrophotometric) |
CPT 82731 | Fetal fibronectin |
CPT 83030, 83033 | Fetal hemoglobin |
CPT 83632 | Human placental lactogen |
CPT 83661-4 | Fetal lung maturity assessment |
CPT 84163 | Pregnancy-associated plasma protein-A |
CPT 84702-3 | Human chorionic gonadotropin |
CPT 85460-1 | Hemoglobin or rbcs, fetal, for fetomaternal hemorrhage |
CPT 88235 | Tissue culture of amniotic fluid or chorionic villus cells |
CPT 88267 | Chromosome analysis using amniotic fluid or chorionic villus cells |
CPT 88269 | In situ chromosome analysis for amniotic fluid cells |
CPT 59400, 59425, 59426, 59510, 59610 | Global billing code for routine prenatal obstetric care |
CMV Diagnosis and CMV-Related Symptoms
| |
ICD-9-CM 078.5 | CMV Disease |
ICD-9-CM 075 | Infectious Mononucleosis |
Routinely Recommended Laboratory Tests
| |
CPT 82947–8, 82950–2, 83036-7 | Glucose Test |
CPT 81007, 81020, 87086, 87088, 87070–1, 87073, P7001 | Urine Culture |
CPT 86592–3, 80055, 86781 | Syphilis Test |
CPT 3513F, 80074, 86704, 86706, 87340, 87341 | Hepatitis B Test |
CPT 3511F, 86631, 86632, 87110, 87270, 87320, 87485, 87486, 87487, 87490, 87491, 87492, 87810; ICD-9 V739 | Chlamydia Test |
CPT 86689, 86701, 86702, 86703, 87390, 87391, 87534, 87535, 87536, 87537, 87538, 87539, G0432, G0433, G0435 | HIV Test |
CPT 85013–4, 85018 | Anemia: Blood count with hematocrit, Blood count with hemoglobin |